Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.41 USD | -3.33% | -6.35% | +44.25% |
13/05 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
13/05 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.25% | 48Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+44.93% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- TScan Therapeutics Names Debora Barton as Chief Medical Officer